Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.77 0.09 +0.77%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a

Neogen Corporation (NEOG) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Neogen Corporation (NEOG) trades at a EV/FCF of 63.4×. Over the past ten years it has ranged from −1,311× (September 2023) to 489× (March 2026); the current reading is higher than 64% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2026 80.2× —
FY2025 −48.4× —
FY2024 −46.9× —
FY2023 −165× —
FY2022 56.6× (31.25%)
FY2021 82.4× 48.35%
FY2020 55.5× 2.77%
FY2019 54.0× (29.23%)
FY2018 76.3× 54.67%
FY2017 49.4× (40.11%)

Quarterly newest first

Period EV/FCF Change
Aug 2026 63.0× (21.51%)
May 2026 80.2× (83.59%)
Feb 2026 489× —
Nov 2025 −109× —
43 more quarters

Against its own ten years

Low −1,311× High 489×
Ten-year median 56.1×
Current reading's percentile 44

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on NEOG